Literature DB >> 29242305

Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency.

Stephanie van Straaten1,2, Marc Bierings3, Paola Bianchi4, Kensuke Akiyoshi5, Hitoshi Kanno6, Isabel Badell Serra7, Jing Chen8, Xiaohang Huang8, Eduard van Beers9, Supachai Ekwattanakit10, Tayfun Güngör11, Wijnanda Adriana Kors12, Frans Smiers13, Reinier Raymakers14, Lucrecia Yanez15, Julian Sevilla16, Wouter van Solinge1, Jose Carlos Segovia17,18, Richard van Wijk19.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29242305      PMCID： PMC5792292          DOI： 10.3324/haematol.2017.177857

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

Review 2.  Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?

Authors:  Janak Adhikari; Priyadarshani Sharma; Vijaya Raj Bhatt
Journal:  Future Oncol       Date:  2016-05-11       Impact factor: 3.404

3.  Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands.

Authors:  Stephanie E Smetsers; Frans J Smiers; Dorine Bresters; Martine C Sonnevelt; Marc B Bierings
Journal:  Br J Haematol       Date:  2016-07-29       Impact factor: 6.998

4.  Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency.

Authors:  V S Tanphaichitr; V Suvatte; S Issaragrisil; C Mahasandana; G Veerakul; V Chongkolwatana; W Waiyawuth; H Ideguchi
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

Review 5.  Red cell pyruvate kinase deficiency: molecular and clinical aspects.

Authors:  Alberto Zanella; Elisa Fermo; Paola Bianchi; Giovanna Valentini
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

6.  Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  A Gratwohl; J Hermans; J M Goldman; W Arcese; E Carreras; A Devergie; F Frassoni; G Gahrton; H J Kolb; D Niederwieser; T Ruutu; J P Vernant; T de Witte; J Apperley
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

7.  Cord blood transplantation in a young child with pyruvate kinase deficiency.

Authors:  Kensuke Akiyoshi; Kazuhito Sekiguchi; Tomoko Okamoto; So-Ichi Suenobu; Tatsuro Izumi
Journal:  Pediatr Int       Date:  2016-03-08       Impact factor: 1.524

Review 8.  Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.

Authors:  S Miwa; H Fujii
Journal:  Am J Hematol       Date:  1996-02       Impact factor: 10.047

9.  Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without host irradiation.

Authors:  M Morimoto; H Kanno; H Asai; T Tsujimura; H Fujii; Y Moriyama; T Kasugai; A Hirono; Y Ohba; S Miwa; Y Kitamura
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

Review 10.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047
View more
  6 in total

1.  Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA.

Authors:  Oscar Quintana-Bustamante; Sara Fañanas-Baquero; Israel Orman; Raul Torres; Philippe Duchateau; Laurent Poirot; Agnès Gouble; Juan A Bueren; Jose C Segovia
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

2.  Allogeneic hematopoietic stem cell transplantation in a 3-year-old boy with congenital pyruvate kinase deficiency: A case report.

Authors:  Zhong-Yang Ma; Xue Yang
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

Review 3.  Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.

Authors:  Hanny Al-Samkari; Eduard J van Beers
Journal:  Ther Adv Hematol       Date:  2021-12-21

Review 4.  Pyruvate Kinase Deficiency: Current Challenges and Future Prospects.

Authors:  Bruno Fattizzo; Francesca Cavallaro; Anna Paola Maria Luisa Marcello; Cristina Vercellati; Wilma Barcellini
Journal:  J Blood Med       Date:  2022-09-01

Review 5.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

6.  The variable manifestations of disease in pyruvate kinase deficiency and their management.

Authors:  Hanny Al-Samkari; Eduard J Van Beers; Kevin H M Kuo; Wilma Barcellini; Paola Bianchi; Andreas Glenthøj; María Del Mar Mañú Pereira; Richard Van Wijk; Bertil Glader; Rachael F Grace
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.